TY - JOUR
T1 - Fibroblast Growth Factor 2 Is Produced By Renal Tubular Cells to Act as a Paracrine Factor in Maladaptive Kidney Repair After Cisplatin Nephrotoxicity
AU - Hu, Xiaoru
AU - Ma, Zhengwei
AU - Li, Siyao
AU - Wen, Lu
AU - Huo, Yuqing
AU - Wu, Guangyu
AU - Manicassamy, Santhakumar
AU - Dong, Zheng
N1 - Publisher Copyright:
Published by Elsevier Inc.
PY - 2023/3/1
Y1 - 2023/3/1
N2 - Kidney repair after injury involves the cross-talk of injured kidney tubules with interstitial fibroblasts and immune cells. Although tubular cells produce multiple cytokines, the role and regulation of specific cytokines in kidney repair are largely undefined. In this study, we detected the induction of fibroblast growth factor 2 (FGF2) in mouse kidneys after repeated low-dose cisplatin (RLDC) treatment and in RLDC-treated renal proximal tubule cells in vitro. We further detected FGF2 in the culture medium of RLDC-treated renal tubular cells but not in the medium of control cells, indicating that RLDC induces FGF2 expression and secretion. Compared with the medium of control cells, the medium of RLDC-treated renal tubular cells was twice as effective in promoting fibroblast proliferation. Remarkably, the proliferative effect of the RLDC-treated cell medium was diminished by FGF2-neutralizing antibodies. In addition, the RLDC-treated cell medium induced the expression of fibrosis-related proteins, which was partially suppressed by FGF2-neutralizing antibodies. In mice, FGF2 deficiency partially prevented RLDC-induced decline in kidney function, loss of kidney weight, renal fibrosis, and inflammation. Together, these results indicate that FGF2 is produced by renal tubular cells after kidney injury and acts as an important paracrine factor in maladaptive kidney repair and disease progression.
AB - Kidney repair after injury involves the cross-talk of injured kidney tubules with interstitial fibroblasts and immune cells. Although tubular cells produce multiple cytokines, the role and regulation of specific cytokines in kidney repair are largely undefined. In this study, we detected the induction of fibroblast growth factor 2 (FGF2) in mouse kidneys after repeated low-dose cisplatin (RLDC) treatment and in RLDC-treated renal proximal tubule cells in vitro. We further detected FGF2 in the culture medium of RLDC-treated renal tubular cells but not in the medium of control cells, indicating that RLDC induces FGF2 expression and secretion. Compared with the medium of control cells, the medium of RLDC-treated renal tubular cells was twice as effective in promoting fibroblast proliferation. Remarkably, the proliferative effect of the RLDC-treated cell medium was diminished by FGF2-neutralizing antibodies. In addition, the RLDC-treated cell medium induced the expression of fibrosis-related proteins, which was partially suppressed by FGF2-neutralizing antibodies. In mice, FGF2 deficiency partially prevented RLDC-induced decline in kidney function, loss of kidney weight, renal fibrosis, and inflammation. Together, these results indicate that FGF2 is produced by renal tubular cells after kidney injury and acts as an important paracrine factor in maladaptive kidney repair and disease progression.
KW - cisplatin
KW - fibroblast growth factor 2
KW - maladaptive kidney repair
KW - renal fibrosis
UR - http://www.scopus.com/inward/record.url?scp=85150314273&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85150314273&partnerID=8YFLogxK
U2 - 10.1016/j.labinv.2022.100009
DO - 10.1016/j.labinv.2022.100009
M3 - Article
C2 - 36925200
AN - SCOPUS:85150314273
SN - 0023-6837
VL - 103
SP - 100009
JO - Laboratory investigation; a journal of technical methods and pathology
JF - Laboratory investigation; a journal of technical methods and pathology
IS - 3
M1 - 100009
ER -